Zheng‐Tuan Guo

Publications

142

Citations

H-Index

2015

Active since

Affiliations

Second Affiliated Hospital of Xi'an Jiaotong University(Current)

Zheng‐Tuan Guo is an author at Second Affiliated Hospital of Xi'an Jiaotong University specializing in medicine, developmental biology, and tumor biology.

ORCID

Top concepts

MedicineStem CellsAngiogenesisCell BiologyTumor BiologyCell SignalingCell DevelopmentVascular BiologySignal TransductionDevelopmental Biology

Publications per year

2015–2021

Publications

Propranolol induces regression of hemangioma cells via the down‐regulation of the PI3K/Akt/eNOS/VEGF pathway

Weikang Pan, Peng Li, Zheng‐Tuan Guo et al. · Pediatric Blood & Cancer · 2015 · 89 citations

Downregulation of miR-382 by propranolol inhibits the progression of infantile hemangioma via the PTEN-mediated AKT/mTOR pathway

Dongfan Li, Peng Li, Zheng‐Tuan Guo et al. · International Journal of Molecular Medicine · 2017 · 43 citations · Full text

Infantile Hemangiomas, Tumor Biology, Angiogenesis +20

miR-378c suppresses Wilms tumor development via negatively regulating CAMKK2

Qiang Yu, Baijun Zheng, Xiang Ji et al. · Acta Biochimica et Biophysica Sinica · 2021 · 10 citations

Rows per page

1–3 of 3